Top of this page
Skip navigation, go straight to the content
UCB is a global biopharmaceutical company focusing on creating value for people living with neurology and immunology conditions.
UCB’s 90-year book is a goldmine to discover!
Twitter Feed
-
UCB is recruiting talents to grow our global IT team. Are you curious to hear what it's like to be a part of it? See the testimonial of Arena. https://t.co/RWS68tYsFH https://t.co/tYwdbrYjRt
— UCB News (@ucb_news) 22.02.2019 -
We are looking for new talents to join our IT team. Are you passionate about innovation and people? If the answer is yes, have a look and apply at https://t.co/nTUueuplnF https://t.co/KZvivAjNLY
— UCB News (@ucb_news) 22.02.2019 -
What do patients want most? The answer, according to a new study of people with severe chronic diseases, is more emotional support https://t.co/Yf1N5iQpmC #InspiredByPatients #DrivenByScience https://t.co/PIAPAolere
— UCB News (@ucb_news) 22.02.2019
Highlights
At UCB, we take our responsibility to the planet very seriously.
UCB Ventures is a €150 million strategic corporate venture fund established in 2017 to further strengthen UCB's ability to create value from novel insights and technologies that can transform the lives of patients suffering from severe diseases. Discove more...
